Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_assertion type Assertion NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_head.
- NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_assertion description "[Genetic and pharmacological studies in mice revealed that elevated CD73-mediated excess renal adenosine preferentially induced A2B adenosine receptor (ADORA2B) production and that enhanced kidney ADORA2B signaling contributes to angiotensin II-induced hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_provenance.
- NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_assertion evidence source_evidence_literature NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_provenance.
- NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_assertion SIO_000772 23584256 NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_provenance.
- NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_assertion wasDerivedFrom befree-2016 NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_provenance.
- NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_assertion wasGeneratedBy ECO_0000203 NP1069089.RApeP52_Jw9Z4YfRB0ePT9DyO7tpM7tFNuRgdWsq3M1eU130_provenance.